PharmiWeb.com - Global Pharma News & Resources

Marketing - Press Releases

Date Title Company
24-Jan-2020 Sanofi Completes Acquisition of Synthorx, Inc. Sanofi
24-Jan-2020 Johnson & Johnson Announces $250 Million Commitment to Support Frontline Health Workers, Reaching 100 Million People by 2030 Davos
24-Jan-2020 Genmab Announces 2019 Net Sales Figures for DARZALEX® (daratumumab) and Achievement of USD 150 Million Sales Milestone in DARZALEX Collaboration with Janssen Genmab
24-Jan-2020 Global Contract Research Organisation Expands Services with Oracle Argus Cloud PharSafer
24-Jan-2020 Growing AXON Brighton Team Relocates to Larger New Office AXON
24-Jan-2020 iOnctura raises EUR 15 million in Series A financing to progress its pipeline into clinical development iOnctura
24-Jan-2020 European CNS specialist Neuraxpharm strengthens expansion into Austrian market with acquisition of easypharm Neuraxpharm Group
24-Jan-2020 Risdiplam (RG7916) Pivotal FIREFISH Study Demonstrated Statistically Significant Improvement in Infants with Type 1 Spinal Muscular Atrophy PTC Therapeutics, Inc
24-Jan-2020 Autolus Announces Proposed Public Offering in the United States Autolus Therapeutics plc
24-Jan-2020 Autolus Announces Pricing of Public Offering Autolus Therapeutics plc
22-Jan-2020 Contract research firm set to double in size following Northern VCT investment Gentronix Ltd
22-Jan-2020 Freeline to present further FLT180a data at EAHAD Freeline
22-Jan-2020 Biotech start-up Seekyo raises €800k with leverage from French Tech Seed Fund Seekyo
22-Jan-2020 Myeloma UK London Paris Ride 2020 Launch Myeloma UK
22-Jan-2020 Hansa Biopharma to host conference call to provide Year-End report 2019 and Business Update Hansa Biopharma
22-Jan-2020 Alliance Pharma PLC - Full Year Trading Update Alliance Pharma plc
22-Jan-2020 TISSIUM Recognized as a French Tech 120 Company TISSIUM
22-Jan-2020 Toxys Strengthens Leadership Team with Appointment of CBO and COO Positions Toxys
22-Jan-2020 Abeona Therapeutics Announces Participation in Inaugural World Congress on Epidermolysis Bullosa Abeona Therapeutics
22-Jan-2020 Novartis receives European licence for Mayzent®▼(siponimod), the first oral treatment for secondary progressive multiple sclerosis (SPMS) with active disease Novartis